title: NOFSA statement on generic bisphosphonates.
authors.forename: J N
authors.initials: JN
authors.lastname: de Jongh
mesh_terms: D019386:Alendronate / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004164:Diphosphonates / Q000493:pharmacokinetics* / Q000627:therapeutic use; D017277:Drug Approval; D006801:Humans; D010024:Osteoporosis / Q000517:prevention & control; D013019:South Africa; D013810:Therapeutic Equivalency
chemical_list: D004164:Diphosphonates; D019386:Alendronate